Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Nov;86(2):311–314. doi: 10.1111/j.1365-2249.1991.tb05815.x

Inhibitory effect of 11 beta-hydroxypregna-1,4-diene-3,20-dione (delta HOP) on lymphocyte proliferation.

C M Rondinone 1, R Schillaci 1, M B Castillo 1, A Roldán 1
PMCID: PMC1554124  PMID: 1934598

Abstract

We have compared the immunosuppressive effect of delta HOP and glucocorticoids on lymphocyte proliferation and IL-1 secretion. The new synthetic steroid only inhibited proliferation of phytohaemagglutinin (PHA)-stimulated human lymphocyte at high concentrations and the effect did not persist after washing out the steroid. In contrast, glucocorticoids produced the classical dose-response inhibition and the effect persisted when they were removed from the cultured medium. Although both steroids decreased IL-1 secretion from human monocytes stimulated with lipopolysaccharide (LPS), they exert the same effect through a different mechanism. The experiments we report suggest that the decrease of IL-1 synthesis produced by delta HOP could be caused by inhibition of LPS phagocytosis. These results support our hypothesis that delta HOP exerts its immunosuppressive and anti-inflammatory effect by a non-genomic mechanism.

Full text

PDF
311

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Lee S. W. The mode of action of anti-rheumatic drugs. 1. Anti-inflammatory and immunosuppressive effects of glucocorticoids. Prog Drug Res. 1989;33:63–81. doi: 10.1007/978-3-0348-9146-2_3. [DOI] [PubMed] [Google Scholar]
  2. Becker J., Grasso R. J. Suppression of phagocytosis by dexamethasone in macrophage cultures: inability of arachidonic acid, indomethacin, and nordihydroguaiaretic acid to reverse the inhibitory response mediated by a steroid-inducible factor. Int J Immunopharmacol. 1985;7(6):839–847. doi: 10.1016/0192-0561(85)90046-3. [DOI] [PubMed] [Google Scholar]
  3. Duval D., Durant S., Homo-Delarche F. Non-genomic effects of steroids. Interactions of steroid molecules with membrane structures and functions. Biochim Biophys Acta. 1983 Aug 11;737(3-4):409–442. doi: 10.1016/0304-4157(83)90008-4. [DOI] [PubMed] [Google Scholar]
  4. González M. D., Rondinone C. M., Burton G., Lantos C. P., Roldán A. Mechanism of the inhibitory effect of 11 beta-hydroxypregna-1, 4-diene-3, 20-dione (delta HOP) at high concentrations in RNA synthesis. Acta Physiol Pharmacol Latinoam. 1986;36(3):303–312. [PubMed] [Google Scholar]
  5. Knudsen P. J., Dinarello C. A., Strom T. B. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol. 1987 Dec 15;139(12):4129–4134. [PubMed] [Google Scholar]
  6. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  7. Roldán A., Burton G., Castillo M. B., Damasco M. C., Lantos C. P. Inhibition of thymocyte RNA synthesis by natural adrenal steroids and their 1,4-diene analogs. Structure-activity correlations using 13C-n.m.r. spectroscopy. J Steroid Biochem. 1981 Dec;15:467–472. doi: 10.1016/0022-4731(81)90316-2. [DOI] [PubMed] [Google Scholar]
  8. Rondinone C. M., Roldán A. Effect of 11 beta OH pregna-1,4-diene-3,20-dione (delta HOP) on thymocyte plasma membranes. Acta Physiol Pharmacol Latinoam. 1990;40(3):357–364. [PubMed] [Google Scholar]
  9. Rondinone C. M., Schillaci R., Lantos C. P., Roldán A. Appearance and persistence of 11 beta-hydroxypregna-1,4-diene-3,20-dione (delta HOP) effect "in vivo". Acta Physiol Pharmacol Latinoam. 1989;39(2):181–188. [PubMed] [Google Scholar]
  10. Warner S. J., Savage N., Mitchell D. Characteristics of lipopolysaccharide interaction with human peripheral-blood monocytes. Biochem J. 1985 Dec 1;232(2):379–383. doi: 10.1042/bj2320379. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES